Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
University Hospital, Basel, Switzerland
Children's Oncology Group
National Cancer Institute (NCI)
AbbVie
National Institutes of Health Clinical Center (CC)
Jonsson Comprehensive Cancer Center
Children's Oncology Group
Novartis
Children's Oncology Group
Acrotech Biopharma Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Albert Einstein College of Medicine
St. Jude Children's Research Hospital
Children's Oncology Group
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
University of Louisville
Fred Hutchinson Cancer Center
Indiana University
Barbara Ann Karmanos Cancer Institute
SillaJen, Inc.
Children's Oncology Group
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Indiana University
University of Minnesota
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital Muenster
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
University of Kentucky
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)